Clinical Trial Update: Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

View source ↗

Summary

Complete status update for a specified drug-use survey of Abilify Prolonged Release Aqueous Suspension for intramuscular injection in Bipolar Disorder I.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Abilify Prolonged Release Aqueous Suspension for IM Injection (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Bipolar Disorder I | Status: COMPLETED